Streetbeat News

Stock Prices

TOST

Toast Inc (NYSE:TOST) reported Q1 earnings with revenue of $1.075 billion, surpassing estimates of $1.041 billion, but with a loss per share of 15 cents, slightly worse than the expected 14 cents loss. The company saw a 32% growth in annualized recurring run-rate to $1.3 billion and a 30% increase in Gross Payment Volume to $34.7 billion. Over 6,000 new locations were added, bringing the total to approximately 112,000. Toast anticipates Q2 gross profit from subscription services and financial technology solutions to be between $320 million and $330 million, with adjusted EBITDA for Q2 between $55 million and $65 million, and full-year adjusted EBITDA between $250 million and $270 million. Shares rose 4.51% after hours to $24.80.

Portfolio Pulse from Adam Eckert

May 07, 2024 | 8:56 pm

SHLS

Shoals Technologies Group's shares dropped following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:56 pm

OPK

OPKO Health (NASDAQ:OPK) reported Q1 2024 GAAP EPS of $(0.12), missing the $(0.10) estimate, and sales of $173.7M, below the $182.99M estimate. This represents a significant decrease from the previous year, with a 500% increase in losses per share and a 26.89% decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:56 pm

DH

Definitive Healthcare's stock trades lower following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:55 pm

SIGA

SIGA Technologies reported a significant increase in Q1 earnings to $0.14 per share from a loss of $(0.01) YoY, with sales rising 205.54% to $25.43M from $8.32M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:55 pm

ANDE

Andersons shares are trading lower following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:55 pm

ASTH

Astrana Health (NASDAQ:ASTH) reported Q1 2024 earnings of $0.31 per share, exceeding estimates by 3.33% and marking a 10.71% increase from the previous year. However, their sales of $404.356M fell short of expectations by 2.29%, despite being a 19.90% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:55 pm

MLNK

MeridianLink (NYSE:MLNK) reported Q1 2024 adjusted EPS of $0.06, missing the consensus estimate of $0.07 by 14.29%, but saw a 500% increase over the previous year's earnings. Sales reached $77.816M, exceeding estimates by 1.15% and marking a 0.88% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:54 pm

DH

Definitive Healthcare (NASDAQ:DH) reported Q1 2024 earnings of $0.08 per share, meeting consensus estimates, and a 33.33% increase from last year. However, sales of $63.480M missed estimates by 0.80%, though they were up 7.23% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:54 pm

ARKO

ARKO reported Q1 2024 earnings with a GAAP EPS of $(0.02), surpassing the $(0.17) estimate, indicating a significant beat by 88.24%. However, its sales of $2.072B slightly missed the $2.079B estimate, marking a minor shortfall of 0.32% and a 0.79% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:54 pm